Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)

Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Radically Resected Non Small Cell Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00763607

Enrollment

454

Registered

2008-10-01

Start date

2007-11-30

Completion date

2009-12-31

Last updated

2022-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Keywords

non small cell lung cancer patients

Brief summary

Aim of the study is to evaluated the role of IGF1R and p95HER2 on prognosis in radically resected non small cell lung cancer patients The primary objective is to correlate the expression of IGF1R and p95HER2 with survival.

Interventions

GENETICProtein expression by immunohistochemistry and immunofluorescence

Protein expression by immunohistochemistry and immunofluorescence

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Radically resected non small cell lung cancer patients with tumor tissue available

Exclusion criteria

* Tumor tissue not available * Clinical data not available

Design outcomes

Primary

Measure	Time frame
Association of different biomarkers with survival	At the end of enrollment

Secondary

Measure	Time frame
Association of a specific biomarker with patient's characteristics	At the end of enrollment

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026